Recently, we revealed that RNF5 inhibition suppresses the lytic replication of Kaposi’s sarcoma-associated herpesvirus and the growth of primary effusion lymphoma by targeting EphA3 and EphA4 [42], emphasizing the positive function of RNF5 in tumor virus replication and tumorigenesis. Here, RNF5 is linked to primary effusion lymphoma.